The Clorox Company $CLX Position Increased by Federated Hermes Inc.

Federated Hermes Inc. lifted its holdings in The Clorox Company (NYSE:CLX) by 35.6% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 460,646 shares of the company’s stock after buying an additional 120,845 shares during the quarter. Federated Hermes Inc. owned approximately 0.38% of Clorox worth $55,310,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Charles Schwab Investment Management Inc. boosted its stake in Clorox by 0.7% in the first quarter. Charles Schwab Investment Management Inc. now owns 752,986 shares of the company’s stock valued at $110,877,000 after acquiring an additional 4,866 shares during the period. Chicago Partners Investment Group LLC bought a new position in Clorox during the 1st quarter worth $265,000. Deutsche Bank AG grew its stake in Clorox by 5.0% during the 1st quarter. Deutsche Bank AG now owns 686,837 shares of the company’s stock worth $101,137,000 after buying an additional 32,639 shares during the last quarter. Citigroup Inc. lifted its stake in Clorox by 67.3% in the first quarter. Citigroup Inc. now owns 157,561 shares of the company’s stock valued at $23,201,000 after buying an additional 63,383 shares during the last quarter. Finally, National Bank of Canada FI boosted its holdings in shares of Clorox by 60.4% during the first quarter. National Bank of Canada FI now owns 94,157 shares of the company’s stock valued at $13,865,000 after acquiring an additional 35,462 shares during the period. Institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling at Clorox

In other Clorox news, Director Pierre R. Breber purchased 4,000 shares of the firm’s stock in a transaction on Friday, November 21st. The shares were purchased at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the transaction, the director owned 13,000 shares in the company, valued at $1,353,690. This represents a 44.44% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.63% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of analyst reports. Morgan Stanley dropped their price objective on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. Jefferies Financial Group reaffirmed a “buy” rating and set a $152.00 price target on shares of Clorox in a report on Tuesday, November 4th. BNP Paribas Exane reduced their price objective on Clorox from $110.00 to $103.00 and set an “underperform” rating for the company in a research report on Tuesday, November 4th. Barclays lowered their target price on Clorox from $112.00 to $108.00 and set an “underweight” rating on the stock in a research report on Tuesday, November 4th. Finally, Rothschild & Co Redburn reduced their price target on Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a research report on Wednesday, November 5th. One equities research analyst has rated the stock with a Buy rating, thirteen have issued a Hold rating and four have given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Reduce” and an average price target of $125.69.

Clorox Stock Performance

CLX opened at $101.01 on Tuesday. The business has a 50 day moving average price of $111.50 and a two-hundred day moving average price of $119.93. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50. The company has a market capitalization of $12.32 billion, a price-to-earnings ratio of 15.86, a price-to-earnings-growth ratio of 0.52 and a beta of 0.57. The Clorox Company has a 1-year low of $98.20 and a 1-year high of $169.61.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The company’s quarterly revenue was down 18.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Research analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be issued a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s dividend payout ratio is presently 77.86%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.